WINT
Windtree Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
+0.00%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.3x
Market Cap
$8.00
MomentumView details →
1D Return
+0.00%
YTD Return
−99.00%
RSI (14)
32.1
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.3x
Market Cap
$8.00
RSI (14)
32.1
MomentumView details →
1D Return
+0.00%
YTD Return
−99.00%
SummaryUpdated Sep 1, 2025
Windtree Therapeutics, Inc. (NASDAQ:WINT) is a clinical-stage biopharmaceutical company founded in 1992 and headquartered in Warrington, Pennsylvania. Originally incorporated as Discovery Laboratories, Inc., the company rebranded to Windtree Therapeutics in April 2016. The company went public in 1995 and is currently a subsidiary of Lee's Pharmaceutical Holdings Limited. Windtree focuses on developing innovative therapeutics for acute cardiovascular diseases and acute pulmonary conditions, with several drug candidates in various phases of clinical trials.
Similar companies
Latest newsMore news →